196 related articles for article (PubMed ID: 2129021)
1. Advances in the management of infectious complications after bone marrow transplantation.
Wingard JR
Bone Marrow Transplant; 1990 Dec; 6(6):371-83. PubMed ID: 2129021
[TBL] [Abstract][Full Text] [Related]
2. Infections in allogeneic bone marrow transplant recipients.
Wingard JR
Semin Oncol; 1993 Oct; 20(5 Suppl 6):80-7. PubMed ID: 8211220
[TBL] [Abstract][Full Text] [Related]
3. [Infections following bone marrow transplantation].
Ljungman P; Andersson J; Sparrelid E
Nord Med; 1995; 110(12):320-1. PubMed ID: 8524635
[TBL] [Abstract][Full Text] [Related]
4. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time.
Gratwohl A; Brand R; Frassoni F; Rocha V; Niederwieser D; Reusser P; Einsele H; Cordonnier C; ;
Bone Marrow Transplant; 2005 Nov; 36(9):757-69. PubMed ID: 16151426
[TBL] [Abstract][Full Text] [Related]
5. Management of infectious complications following liver transplantation.
Keating MR; Wilhelm MP
Curr Clin Top Infect Dis; 1993; 13():226-49. PubMed ID: 8397912
[No Abstract] [Full Text] [Related]
6. Treatment of steroid-resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies.
Hebart H; Ehninger G; Schmidt H; Berner B; Reuss-Borst M; Waller HD; Müller CA; Einsele H
Bone Marrow Transplant; 1995 Jun; 15(6):891-4. PubMed ID: 7581087
[TBL] [Abstract][Full Text] [Related]
7. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
[TBL] [Abstract][Full Text] [Related]
8. Infectious complications during autotransplantation.
Reed EC
Hematol Oncol Clin North Am; 1993 Jun; 7(3):717-35. PubMed ID: 8344887
[TBL] [Abstract][Full Text] [Related]
9. Infectious complications of acute and chronic GVHD.
Young JA
Best Pract Res Clin Haematol; 2008 Jun; 21(2):343-56. PubMed ID: 18503997
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281
[TBL] [Abstract][Full Text] [Related]
11. Infection in the bone marrow transplant recipient.
Walter EA; Bowden RA
Infect Dis Clin North Am; 1995 Dec; 9(4):823-47. PubMed ID: 8747768
[TBL] [Abstract][Full Text] [Related]
12. [Infectious complications in bone marrow transplantation].
Gómez Casares MT; Alsar MJ; Conde E; Muruzabal MJ; Pérez Encinas M; Baro J; Iriondo A; Richard C; Garijo J; Aguado JM
Med Clin (Barc); 1991 Mar; 96(11):405-9. PubMed ID: 2046427
[TBL] [Abstract][Full Text] [Related]
13. Infectious complications of marrow transplant: risk factors for infection.
Meyers JD; Bowden RA; Counts GW
Prog Clin Biol Res; 1989; 309():357-66. PubMed ID: 2675104
[TBL] [Abstract][Full Text] [Related]
14. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
15. Infectious complications of bone marrow transplantation.
Winston DJ; Ho WG; Champlin RE; Gale RP
Exp Hematol; 1984 Mar; 12(3):205-15. PubMed ID: 6368256
[No Abstract] [Full Text] [Related]
16. Special considerations for the patient undergoing allogeneic or autologous bone marrow transplantation.
Hiemenz JW; Greene JN
Hematol Oncol Clin North Am; 1993 Oct; 7(5):961-1002. PubMed ID: 8226568
[TBL] [Abstract][Full Text] [Related]
17. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
19. Infections and immunodeficiency in bone marrow transplantation.
Tutschka PJ
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S22-9. PubMed ID: 3041357
[TBL] [Abstract][Full Text] [Related]
20. [Infections in solid organ transplant recipients].
Cuellar-Rodríguez J; Sierra-Madero JG
Rev Invest Clin; 2005; 57(2):368-80. PubMed ID: 16524080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
